| No. | Ticker▲ | QT Score | Company | Sector | Industry | Country | Market Cap | P/E | Price | Change | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ABCL | 61 | AbCellera Biologics Inc. | Healthcare | Biotechnology | Canada | 2.12B | - | 9.59 | 38.31% | 6,363,245 |
| 2 | GHRS | 78 | GH Research PLC | Healthcare | Biotechnology | Ireland | 2.08B | - | 29.76 | -1.68% | 337,152 |
| 3 | MESO | 47 | Mesoblast Limited | Healthcare | Biotechnology | AU | 2.04B | - | 16.66 | 4.55% | 80,929 |
| 4 | NKTR | 62 | Nektar Therapeutics | Healthcare | Biotechnology | USA | 2.19B | - | 74.96 | -1.99% | 898,833 |
| 5 | RAPP | 79 | Rapport Therapeutics, Inc. Common Stock | Healthcare | Biotechnology | USA | 2.18B | - | 46.10 | 1.35% | 246,055 |
| 6 | STOK | 71 | Stoke Therapeutics, Inc. | Healthcare | Biotechnology | USA | 2.11B | - | 32.26 | -1.39% | 866,577 |
| 7 | TSHA | 61 | Taysha Gene Therapies, Inc. | Healthcare | Biotechnology | USA | 2.10B | - | 6.46 | -1.52% | 1,929,504 |
| 8 | ZBIO | 87 | Zenas BioPharma, Inc. | Healthcare | Biotechnology | USA | 2.05B | - | 32.08 | -1.08% | 264,044 |